These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33002071)

  • 41. [The SPRINT Research. A Randomized Trial of Intensive versus Standard Blood-Pressure Control].
    Widimský J
    Vnitr Lek; 2016 Jan; 62(1):44-7. PubMed ID: 26967236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg.
    Tajeu GS; Booth JN; Colantonio LD; Gottesman RF; Howard G; Lackland DT; O'Brien EC; Oparil S; Ravenell J; Safford MM; Seals SR; Shimbo D; Shea S; Spruill TM; Tanner RM; Muntner P
    Circulation; 2017 Aug; 136(9):798-812. PubMed ID: 28634217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.
    Williamson JD; Supiano MA; Applegate WB; Berlowitz DR; Campbell RC; Chertow GM; Fine LJ; Haley WE; Hawfield AT; Ix JH; Kitzman DW; Kostis JB; Krousel-Wood MA; Launer LJ; Oparil S; Rodriguez CJ; Roumie CL; Shorr RI; Sink KM; Wadley VG; Whelton PK; Whittle J; Woolard NF; Wright JT; Pajewski NM;
    JAMA; 2016 Jun; 315(24):2673-82. PubMed ID: 27195814
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results.
    Huang C; Dhruva SS; Coppi AC; Warner F; Li SX; Lin H; Nasir K; Krumholz HM
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29133522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study.
    Li C; Chen K; Cornelius V; Tomeny E; Wang Y; Yang X; Yuan X; Qin R; Yu D; Wu Z; Wang D; Chen T
    PLoS Med; 2021 Mar; 18(3):e1003515. PubMed ID: 33661907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of Acute Kidney Injury with Cardiovascular Events and Death in Systolic Blood Pressure Intervention Trial.
    Dieter BP; Daratha KB; McPherson SM; Short R; Alicic RZ; Tuttle KR
    Am J Nephrol; 2019; 49(5):359-367. PubMed ID: 30939480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes in adults with systolic blood pressure between 130 and 139 mmHg in Action to Control Cardiovascular Risk in Diabetes Blood Pressure trial and Systolic Blood Pressure Intervention Trial.
    Contreras G; Lu L; Tamariz L; Rocco MV; Papademetriou V; Kostis JB; Pisoni R; Glasser SP; Sweeney ME; Basile J; Gren LH; Zamanian S; Cushman WC;
    J Hypertens; 2020 Aug; 38(8):1567-1577. PubMed ID: 32371767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Blood pressure: the lower the better? Maybe yes].
    Verdecchia P; Angeli F; Aita A; Bartolini C; Garofoli M; Reboldi G
    G Ital Cardiol (Rome); 2016 May; 17(5):335-8. PubMed ID: 27310905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between HDL-C and intensive blood pressure control in patients with hypertension: A post-hoc analysis of SPRINT.
    Liu R; Cheng W
    J Clin Hypertens (Greenwich); 2024 Mar; 26(3):225-234. PubMed ID: 38318688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intensive Blood Pressure Treatment Reduced Stroke Risk in Patients With Albuminuria in the SPRINT Trial.
    Leitão L; Soares-Dos-Reis R; Neves JS; Baptista RB; Bigotte Vieira M; Mc Causland FR
    Stroke; 2019 Dec; 50(12):3639-3642. PubMed ID: 31637971
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Intensive Blood Pressure Control and Living Arrangement on Cardiovascular Outcomes by Race: Post Hoc Analysis of SPRINT Randomized Clinical Trial.
    Inoue K; Watson KE; Kondo N; Horwich T; Hsu W; Bui AAT; Duru OK
    JAMA Netw Open; 2022 Mar; 5(3):e222037. PubMed ID: 35285922
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low on-treatment diastolic blood pressure and cardiovascular outcome: A post-hoc analysis using NHLBI SPRINT Research Materials.
    Sobieraj P; Lewandowski J; Siński M; Gaciong Z
    Sci Rep; 2019 Sep; 9(1):13070. PubMed ID: 31506550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT.
    Beddhu S; Shen J; Cheung AK; Kimmel PL; Chertow GM; Wei G; Boucher RE; Chonchol M; Arman F; Campbell RC; Contreras G; Dwyer JP; Freedman BI; Ix JH; Kirchner K; Papademetriou V; Pisoni R; Rocco MV; Whelton PK; Greene T
    J Am Soc Nephrol; 2019 Aug; 30(8):1523-1533. PubMed ID: 31324734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Benefits of Intensive Versus Standard Blood Pressure Treatment According to Fine Particulate Matter Air Pollution Exposure: A Post Hoc Analysis of SPRINT.
    Al-Kindi SG; Brook RD; Bhatt U; Brauer M; Cushman WC; Hanson HA; Kostis J; Lash JP; Paine R; Raphael KL; Rapp S; Tamariz L; Wright JT; Rajagopalan S;
    Hypertension; 2021 Mar; 77(3):813-822. PubMed ID: 33517683
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial).
    Patel KK; Arnold SV; Chan PS; Tang Y; Pokharel Y; Jones PG; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28373269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension from the Systolic Blood Pressure Intervention Trial.
    Foy CG; Lovato LC; Vitolins MZ; Bates JT; Campbell R; Cushman WC; Glasser SP; Gillespie A; Kostis WJ; Krousel-Wood M; Muhlestein JB; Oparil S; Osei K; Pisoni R; Segal MS; Wiggers A; Johnson KC;
    J Hypertens; 2018 Apr; 36(4):904-915. PubMed ID: 29493562
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of baseline cardiovascular risk on the outcomes of intensive blood pressure intervention: a post hoc analysis of the China rural hypertension control project.
    Sun G; Wang C; Ye N; Shi C; Ouyang N; Qiao L; Li G; Zhang L; Yu Y; Li Z; Zhou Y; Chen Z; Zhang S; Zhang P; Geng D; Miao W; Liu S; Sun Y
    BMC Med; 2024 Jun; 22(1):258. PubMed ID: 38902731
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systolic blood pressure trajectory and cardiovascular outcomes: An analysis using data in the Systolic Blood Pressure Intervention Trial.
    Lee CL; Wang JS
    Int J Clin Pract; 2020 Mar; 74(3):e13450. PubMed ID: 31755625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intensive Blood Pressure Treatment for Resistant Hypertension.
    Tsujimoto T; Kajio H
    Hypertension; 2019 Feb; 73(2):415-423. PubMed ID: 30580680
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.
    Zhang W; Zhang S; Deng Y; Wu S; Ren J; Sun G; Yang J; Jiang Y; Xu X; Wang TD; Chen Y; Li Y; Yao L; Li D; Wang L; Shen X; Yin X; Liu W; Zhou X; Zhu B; Guo Z; Liu H; Chen X; Feng Y; Tian G; Gao X; Kario K; Cai J;
    N Engl J Med; 2021 Sep; 385(14):1268-1279. PubMed ID: 34491661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.